SC Ropharma (BSE:RPH) YoY EBITDA Growth : 8.33% (As of Jun. 2024)

View and export this data going back to 1997. Start your Free Trial

What is SC Ropharma YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. SC Ropharma's YoY EBITDA Growth for the quarter that ended in Jun. 2024 was 8.33%.

SC Ropharma's EBITDA per Share for the six months ended in Jun. 2024 was lei0.05.

SC Ropharma YoY EBITDA Growth Historical Data

The historical data trend for SC Ropharma's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SC Ropharma YoY EBITDA Growth Chart

SC Ropharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

12.24

16.36

21.88

-6.41

23.29

SC Ropharma Semi-Annual Data
	Dec12	Dec13	Dec14	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
YoY EBITDA Growth	Get a 7-Day Free Trial															9.68	-17.02	41.18	5.13	8.33

SC Ropharma YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

SC Ropharma's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(0.09	-	0.073)	/	\| 0.073 \|
=	23.29 %

SC Ropharma's YoY EBITDA Growth for the quarter that ended in Jun. 2024 is calculated as:

	YoY EBITDA Growth (Q: Jun. 2024 )
=	(EBITDA per Share (Q: Jun. 2024 )	-	EBITDA per Share (Q: Jun. 2023 ))	/	\| EBITDA per Share (Q: Jun. 2023 )) \|
=	(0.052	-	0.048)	/	\| 0.048 \|
=	8.33 %

SC Ropharma YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of SC Ropharma's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

SC Ropharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SC Ropharma SA (BSE:RPH) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

Strada Iuliu Maniu Nr. 55, ETAJ 1, Brasow, ROU, 500091

Website

http://www.ropharma.ro

SC Ropharma SA is engaged in the production, distribution, and Retail sale of pharmaceutical products in specialized stores. Its product portfolio comprises over 50 products in the form of tablets, powders, capsules, and syrups covering 21 therapeutic areas.

SC Ropharma Headlines

No Headlines